Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
about
Executive dysfunction in Parkinson's disease and timing deficitsDoes vigorous exercise have a neuroprotective effect in Parkinson disease?Mild cognitive impairment in Parkinson's diseaseCognitive function in early Parkinson's disease: a population-based studyTreatment of psychosis and dementia in Parkinson's disease.A randomized controlled trial of an enhanced interdisciplinary community based group program for people with Parkinson's disease: study rationale and protocol.Road safety in drivers with Parkinson diseaseImpaired verbal memory in Parkinson disease: relationship to prefrontal dysfunction and somatosensory discriminationProfile of cognitive impairment in Parkinson's diseaseEvaluation of mild cognitive impairment subtypes in Parkinson's disease.GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease.Resting-state functional brain networks in Parkinson's disease.Modified serpinA1 as risk marker for Parkinson's disease dementia: Analysis of baseline data.Metabolic brain networks in neurodegenerative disorders: a functional imaging approach.Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson diseaseMultiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson diseaseVerbal memory is associated with structural hippocampal changes in newly diagnosed Parkinson's diseaseAssociations between cognitive impairment and motor dysfunction in Parkinson's diseaseHippocampal and ventricular changes in Parkinson's disease mild cognitive impairmentOlfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's diseaseParkinson's disease: the quintessential neuropsychiatric disorderThe range and nature of non-motor symptoms in drug-naive Parkinson's disease patients: a state-of-the-art systematic reviewInitial cognitive decline is associated with cortical thinning in early Parkinson disease.The spectrum of cognitive impairment in Lewy body diseasesLow clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic studyMild cognitive impairment in prediagnosed Huntington disease.Laser Acupuncture at HT7 Acupoint Improves Cognitive Deficit, Neuronal Loss, Oxidative Stress, and Functions of Cholinergic and Dopaminergic Systems in Animal Model of Parkinson's Disease.Incidental Lewy body disease: clinical comparison to a control cohort.Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.Premotor and nonmotor features of Parkinson's disease.An update on brain imaging in parkinsonian dementiaTrends and issues in characterizing early cognitive changes in Parkinson's disease.APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.Lewy body dementias.Seniors with Parkinson's disease: initial medical treatment.The clinical symptoms of Parkinson's disease.V-TIME: a treadmill training program augmented by virtual reality to decrease fall risk in older adults: study design of a randomized controlled trial.Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson's disease.Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease.
P2860
Q21090466-047B7BF6-936B-4EFF-88BB-0E6194EE7E39Q22241647-599EE417-CC6C-40F3-A114-6C1EE2AB732FQ27007766-49E84F1E-CA98-4E8D-86FF-A8E92BDEBAFAQ28249085-64CD1C24-34BD-4EA5-BB17-42D6D1FA06D7Q30358337-EAB4F798-9167-42F7-9B64-0C42EB3C4DCCQ30467565-E35E5CBE-FC12-4067-B736-A172495B4CD3Q30492237-F28FC5C4-0D86-4D2E-9615-9DB2F3F8C780Q30492753-1606A2A5-F354-499B-8AB8-20C3FF3ED39EQ30498333-F39C8E80-9038-4B6D-87F0-BC8978AEC1A6Q30577625-26E6F339-54D3-4A51-9165-27E730D1F2A5Q30700188-DFF96BE8-FF65-4920-949D-ABBDA3F3090FQ30983855-CC26155C-9C41-4635-A3E4-428DA409CDF0Q31096478-F3F93C82-CD54-47CA-A566-BED8C707C7D4Q33504970-1CA45CD2-8BD7-431B-8EC9-E94715BA9035Q33516505-F81A8769-C4F1-4C56-A681-86FD5350397CQ33698810-960079D6-F362-4B87-A2DC-B6D1E32420E9Q33699736-9973BBC2-0893-4E59-9D91-D76C841DBC4DQ33810161-146CA60C-310B-495D-8452-49A5CE8A199CQ33829483-6DDC00DE-BE3F-46DF-9065-F6AA2AF59267Q33882719-D67FEF80-5C8F-4E72-9EBC-9068EC2725F3Q33917094-651DC2DD-8EA2-4B54-A592-D882603AA558Q33917211-ECA54886-D827-481C-A8CB-1F5EEB287C5FQ33927210-E47C9364-4DB9-4736-B430-ED5A01886ECEQ34019751-BD67C17F-56D8-450C-9C86-567725BDBEB5Q34043770-B871149B-6850-49D9-BAFB-1B4678B17A38Q34053274-7CF2FF79-9E93-4D3A-BEEF-37380F7DF6F1Q34069090-88165249-AF9F-48D1-85FA-619AAD880934Q34111184-2D84D7A8-288E-4D9B-8AA0-C7DF71EE3EC1Q34140404-4E440E7E-59C0-4510-81C8-C562AEF55EA2Q34183061-B337A89B-DD3F-492B-837F-37395819212FQ34274224-DD4897FF-AABE-4056-B678-6DD9BF287580Q34327937-EFAB86C2-D09E-4CED-8EE0-E0C167B1A715Q34403392-14C39129-EDE6-4FCE-A331-C8837F46C83CQ34490496-A425E38C-8821-49E3-8463-1A147BA891A8Q34502646-995BC2ED-BE48-4717-9661-0E8820732986Q34508143-3F63C880-3D4E-4804-A410-469265F7C484Q34533843-74101B09-098B-49F0-AABF-46F0DAAEE35EQ34578767-8C749C45-32D9-4265-B1F4-EB7E7413E7A6Q34766509-3509DD69-6E49-417D-9A30-988289333D4FQ35040454-9F3F6E2E-3C3A-45F2-BF4D-E881D53AC065
P2860
Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Cognitive impairment in incide ...... the Norwegian ParkWest study.
@en
Cognitive impairment in incide ...... the Norwegian ParkWest study.
@nl
type
label
Cognitive impairment in incide ...... the Norwegian ParkWest study.
@en
Cognitive impairment in incide ...... the Norwegian ParkWest study.
@nl
prefLabel
Cognitive impairment in incide ...... the Norwegian ParkWest study.
@en
Cognitive impairment in incide ...... the Norwegian ParkWest study.
@nl
P2093
P1433
P1476
Cognitive impairment in incide ...... : the Norwegian ParkWest study
@en
P2093
J P Larsen
Norwegian ParkWest Study Group
O B Tysnes
P304
P356
10.1212/01.WNL.0000338632.00552.CB
P407
P577
2008-11-19T00:00:00Z